Treatment of Cough in Pregnant Women

Initial Assessment and Cause Identification

For a pregnant woman with cough, the American College of Obstetricians and Gynecologists recommends identifying the underlying cause and treating accordingly, prioritizing albuterol for asthma-related symptoms and ipratropium bromide for non-asthmatic cough, while avoiding withholding necessary medications as uncontrolled symptoms pose greater risk to the fetus than the treatments themselves 1
The approach to cough in pregnancy depends on determining whether the cough is related to asthma or bronchospasm, characterized by wheezing, shortness of breath, chest tightness, or history of asthma, as recommended by the American Academy of Allergy, Asthma, and Immunology 2, 3
Post-infectious cough is considered if there is a recent upper respiratory infection with persistent dry cough, according to the American College of Chest Physicians 4

The American Academy of Allergy, Asthma, and Immunology recommends albuterol as the preferred short-acting beta-agonist for asthma-related cough in pregnancy, due to its extensive safety data, with no evidence of fetal injury 2, 3, 1
The dosing for albuterol is 2-4 puffs via MDI every 4-6 hours as needed, as recommended by the American Academy of Allergy, Asthma, and Immunology 5
For persistent asthma symptoms requiring daily medication, the American Academy of Allergy, Asthma, and Immunology recommends budesonide as the preferred inhaled corticosteroid, due to its reassuring pregnancy safety data 2, 3, 1

The American College of Obstetricians and Gynecologists recommends ipratropium bromide as the only recommended inhaled anticholinergic for cough suppression in pregnancy 1
Ipratropium bromide has been shown to attenuate symptoms in controlled trials for post-infectious cough, according to the American College of Chest Physicians 4
The dosing options for ipratropium bromide are MDI: 4-8 puffs as needed, or Nebulizer: 0.25 mg every 20 minutes for 3 doses, then every 2-4 hours as needed, as recommended by the American Academy of Allergy, Asthma, and Immunology 5

The American College of Obstetricians and Gynecologists recommends that inadequate control of respiratory symptoms poses greater risk to the fetus than the medications used to treat them, emphasizing the importance of proper management 1
The American College of Obstetricians and Gynecologists advises avoiding oral decongestants, especially in the first trimester, due to potential associations with cardiac, ear, gut, and limb abnormalities 1
The American College of Chest Physicians states that antibiotics have no role in treating post-infectious cough unless bacterial sinusitis or early pertussis infection is confirmed 4

The American College of Obstetricians and Gynecologists warns against withholding necessary respiratory medications due to pregnancy concerns, as this is the most dangerous error, harming both mother and fetus more than the treatments 1
The American College of Chest Physicians cautions against assuming all cough is benign, and recommends considering alternative diagnoses beyond post-infectious cough if symptoms persist beyond 8 weeks 4
The American College of Chest Physicians advises against using antibiotics empirically for viral post-infectious cough 4

The British Thoracic Society recommends immediate evaluation if the patient has coughing up blood, significant breathlessness, prolonged fever with systemic illness, or symptoms persisting beyond 3 weeks without improvement 6

The American College of Obstetricians and Gynecologists recommends maintaining adequate hydration and nutrition throughout pregnancy to support immune function 1